Announced Fri, 3 Jul · 18:47 IST
Board Meeting Outcome: Independent Director Regularization and Statutory Auditor Appointment
Management Changes View source PDF
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹88.99
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.3-2.8+0.0-2.7+1.1-2.5-5.6———
Up moveDown movePending
AI summary
Indo Us Biotech board met on July 3, 2026 and approved seeking shareholder nod via postal ballot for two items: regularizing Mrs. Hemanshi Darsh Soni as Non-Executive Independent Director for 5 years, and appointing M/s Bhagat and Associates as Statutory Auditor for 5 years from June 16, 2026. Postal ballot voting runs from July 5 to August 3, 2026.
Likely market impact
Routine governance items. Postal ballot seeks shareholder nod for a new independent director and statutory auditor. No material impact on stock expected.